TY - JOUR
T1 - Recombinant human erythropoietin therapy in end stage renal failure
AU - Watson, A. J.
AU - Spivak, J. L.
PY - 1988
Y1 - 1988
N2 - In summary, the initial studies of etythropoietin in anemic patients with end-stage renal disease are encouraging. Hopefully, larger, ongoing studies will provide answers to remaining questions such as blood pressure regulation, altered dialysis clearance, potential problems with arteriovenous access and the appropriate target hematocrit in these patients.
AB - In summary, the initial studies of etythropoietin in anemic patients with end-stage renal disease are encouraging. Hopefully, larger, ongoing studies will provide answers to remaining questions such as blood pressure regulation, altered dialysis clearance, potential problems with arteriovenous access and the appropriate target hematocrit in these patients.
UR - http://www.scopus.com/inward/record.url?scp=0024270213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024270213&partnerID=8YFLogxK
U2 - 10.1002/j.1552-4604.1988.tb05719.x
DO - 10.1002/j.1552-4604.1988.tb05719.x
M3 - Review article
C2 - 3072351
AN - SCOPUS:0024270213
SN - 0091-2700
VL - 28
SP - 1086
EP - 1088
JO - Journal of clinical pharmacology
JF - Journal of clinical pharmacology
IS - 12
ER -